Public trial registry of the CCC-Munich

Trial C-144-01 (TIL)

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
C-144-01 (TIL)
World
Full title
:

A Phase 2, Multicenter Study to Assess the Efficacy and Safety of Autologous Tumor Infiltrating Lymphocytes (LN-144) for Treatment of Patients with Metastatic Melanoma Z-Nummer: 362 - CAVE: Screening nur nach OK von Sponsor!

World
NCT number
:
World
Responsible organization
:
3. Med 3. Med Ismaninger Str. 22 81675 München Germany
Indications
Classification Code Description
- Skincancers
Trial design
World
Phase
:
II
Status
World
Status
:
Recruitment finished
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Sonstige - Therapieart: palliativ

Participants
Function Prename Surname Organization
World Responsible contact Angela Krackhardt 3. Med 3. Med Ismaninger Str. 22 81675 München Germany Magnifier